Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Discussing the zoster vaccine: an interview with Julie Gerberding, president of Merck Vaccines.

Gerberding J.

Popul Health Manag. 2012 Dec;15(6):382-4. doi: 10.1089/pop.2012.1561. Epub 2012 Oct 22. No abstract available.

PMID:
23088664
2.

Varicella-zoster vaccine for the prevention of herpes zoster.

Kimberlin DW, Whitley RJ.

N Engl J Med. 2007 Mar 29;356(13):1338-43. Review. No abstract available.

PMID:
17392303
3.

Zoster vaccine live (Oka/Merck).

Robinson DM, Perry CM.

Drugs Aging. 2006;23(6):525-31; discussion 532-3. Review.

PMID:
16872235
4.

Zoster vaccine live for the prevention of shingles in the elderly patient.

Zussman J, Young L.

Clin Interv Aging. 2008;3(2):241-50. Review.

5.

A model of Varicella-Zoster reactivation.

Forde JE, Meeker B.

Math Biosci Eng. 2010 Oct;7(4):765-77. doi: 10.3934/mbe.2010.7.765.

PMID:
21077706
6.

[The clinical and epidemic characteristics of shingles (herpes zoster) and its prevention with vaccines].

Afonina NM, Mikheeva IV.

Ter Arkh. 2013;85(11):130-3. Review. Russian.

PMID:
24432613
7.

It is an exciting time in the study and management of shingles and postherpetic neuralgia (PHN). Introduction.

Yawn BP.

Popul Health Manag. 2012 Dec;15(6):381. doi: 10.1089/pop.2012.1565. Epub 2012 Oct 22. No abstract available.

PMID:
23088663
8.

Herpes zoster in an HIV-negative man on ritonavir.

Miller KD, Piscitelli SC, Davey RT Jr.

AIDS Patient Care STDS. 2000 Oct;14(10):527-8. No abstract available.

PMID:
11054935
9.

Differences between the varicella vaccines; using dabigatran.

DeDea L.

JAAPA. 2011 Apr;24(4):23. No abstract available.

PMID:
21534377
10.

Pathogenesis and current approaches to control of varicella-zoster virus infections.

Gershon AA, Gershon MD.

Clin Microbiol Rev. 2013 Oct;26(4):728-43. doi: 10.1128/CMR.00052-13. Review.

11.

Varicella-zoster virus-specific immune responses in elderly recipients of a herpes zoster vaccine.

Levin MJ, Oxman MN, Zhang JH, Johnson GR, Stanley H, Hayward AR, Caulfield MJ, Irwin MR, Smith JG, Clair J, Chan IS, Williams H, Harbecke R, Marchese R, Straus SE, Gershon A, Weinberg A; Veterans Affairs Cooperative Studies Program Shingles Prevention Study Investigators.

J Infect Dis. 2008 Mar 15;197(6):825-35. doi: 10.1086/528696.

12.

Zoster vaccine live.

Kockler DR, McCarthy MW.

Pharmacotherapy. 2007 Jul;27(7):1013-9. Review.

PMID:
17594207
13.

Zoster vaccine: current status and future prospects.

Oxman MN.

Clin Infect Dis. 2010 Jul 15;51(2):197-213. doi: 10.1086/653605. Review.

14.

Varicella-zoster virus vaccine--grown-ups need it, too.

Gilden DH.

N Engl J Med. 2005 Jun 2;352(22):2344-6. No abstract available.

PMID:
15930426
15.

Vaccines for preventing herpes zoster in older adults.

Leme LE.

Sao Paulo Med J. 2014;132(4):255. No abstract available.

16.

[Herpes zoster and postherpetic neuralgia: advantages of the vaccination].

Cañada JL.

Rev Esp Quimioter. 2009 Nov;22 Suppl 1:19-21. Review. Spanish. No abstract available.

17.
18.

[How I prevent...herpes zoster by vaccination].

Nikkels AF, Piérard GE.

Rev Med Liege. 2007 Jan;62(1):44-7. Review. French.

PMID:
17343129
19.

Herpes zoster (shingles).

Wilson DD.

Nurse Pract. 2014 May 12;39(5):15-6. doi: 10.1097/01.NPR.0000445958.65687.b0. No abstract available.

PMID:
24739427
20.

Strategies for herpes zoster vaccination of immunocompromised patients.

Cohen JI.

J Infect Dis. 2008 Mar 1;197 Suppl 2:S237-41. doi: 10.1086/522129. Review.

Items per page

Supplemental Content

Write to the Help Desk